Anti-EGFR monoclonal antibody (fully human)
Panitumumab (Specialist drug)
Brand names: Vectibix
Adult dose
Dose: Specialist initiation only — refer to BNF/SmPC
Route: IV
Frequency: every 2 weeks
Clinical pearls
- KRAS/NRAS wild-type metastatic colorectal cancer
- Specialist oncology
Contraindications
- Hypersensitivity
- Severe ILD
- KRAS-mutated tumours (no benefit)
Side effects
- Acneiform rash
- Hypomagnesaemia
- Diarrhoea
- Infusion reactions
- ILD
- Photosensitivity
Interactions
- Live vaccines
Monitoring
- Magnesium
- Electrolytes
- Skin reactions
Reference: BNF; NICE TA439; SmPC; https://bnf.nice.org.uk/drugs/panitumumab-specialist-drug/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Vancomycin Dosing Calculator · Drug Dosing
- Phenytoin Correction for Albumin / Renal Failure · Drug Dosing
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- Tisdale Risk Score for QT Prolongation · Arrhythmia
- Bazett Corrected QT Interval (QTc) Calculator · Arrhythmia
- DAPT Score for Dual Antiplatelet Therapy Duration · Antiplatelet Therapy